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ABSTRACT 
Objective: The objective of the study was to evaluate the antifungal activity of biphenyl-2,6-diethanone derivatives against Cryptococcus 
neoformans. 
Methods: Antifungal activity of biphenyl derivatives were evaluated against C. neoformans. Zone of inhibition by disc diffusion method and 
minimum inhibitory concentration (MIC) using micro-broth dilution method was performed as per clinical and laboratory standard institute (CLSI). 
Melanin was extracted using 1M KOH, purified using 6M HCL and its reduction was assayed spectrophotometrically at 530 nm. Laccase activity was 
measured using L-DOPA as substrate and was assayed spectrophotometrically at 480 nm. Time kill assay was also performed to compare the 
antifungal potency of the test compound against azole drug. 
Results: Zone of inhibition of 12 mm diameter was estimated against C. neoformans. MIC80
Conclusion: The outcome of in vitro antifungal studies indicated that compound 1e demonstrated maximum reduction of melanin and laccase 
activity in C. neoformans. In conclusion, biphenyl-2,6-diethanone derivatives possess significant antifungal property which can be explored further 
for lead generation.  
 of compound 1e was calculated as 50µg/ml. 63.67% 
decrease in melanization and 57.44% laccase activity reduction was determined. The Time-kill assay illustrated that the compound 1e inhibited the 
growth of C. neoformans cells in almost the same duration as observed in fluconazole.  
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C. neoformans has emerged as a serious human pathogen in the past 
few years. It causes lung infections and may spread in the brain; 
causing meningoencephalitis. It has become the leading mycological 
cause of morbidity and mortality among immunocompromised 
patients [1]. It forms a creamy colored colony on potato dextrose 
agar (PDA) but produces melanized cells in the presence of 
exogenous precursor like L-DOPA which is catalysed by laccase 
enzyme of C. neoformans. Melanin has been reported to increase 
virulence and antifungal drug resistance by growing in a biofilm. 
Currently, azole antifungal drugs are the mainstay for the treatment 
of cryptococcosis infection. However, increased antifungal drug 
resistance caused through drug efflux by the fungal cellular 
machinery raises an urgent need to discover novel antifungal agents 
targeting cryptococcosis infection [2, 3].  
Biphenyl scaffolds have received considerable attention due to their 
wide range of biological activities. Substituted biphenyls have been 
reported as an important pharmacologically important molecules 
exhibiting significant antifungal activity against Candida albicans and 
Aspergillus niger [4,5]. This literature prompted us to investigate 
antifungal activity of biphenyl-2,6-diethanone derivatives. The 
synthesis of derivatives of biphenyl-2,6-diethanones has been 
previously done by our group (unpublished results). The present 
study focusses on evaluating antifungal activity of synthesized 
biphenyl-2,6-diethanone derivatives against C. neoformans. The 
biphenyl-2,6-diethanone derivatives evaluated for antifungal activity 
are depicted in table 1. These derivatives were synthesized using 
procedures previously reported [6]. 
C. neoformans, ATCC 66031 (KwikStik, Himedia) was maintained on 
PDA plates at 30ºC for 36 h* [7]. Efficacy of the compound was 
tested by measuring the zone of inhibition using disc diffusion 
method. Fluconazole (1 mg/ml) and methanol were used as positive 
and negative controls respectively. In vitro susceptibility assay was 
performed using broth microdilution method in a 96 well plate as 
per CLSI protocol, formerly known as NCCLS [8]. MIC80
 
 was 
calculated to find the concentration at which the test compound was 
potent enough to kill 80% of C. neoformans cells. This concentration 
was taken up for further experiments. 
Table 1: Substituted Biphenyl-2,6-diethanone derivatives 
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In0T 0T1TC. neoformans1T, melanin has a complex architecture with multiple 
layers and a granular surface which enhances their virulence [9]. 
Literature reports have indicated that cryptococcosis infection is 
associated with the presence of melanized colonies in the brain tissue.0T 
Hence, t0The effect of the test compounds on melanin formation was 
determined according to the method described by Rosas et al., 2000 
[10]. Melanin was extracted using glycolytic and proteolytic enzymes, 
denaturant, organic extractions, and finally boiling in 6M HCl. The 
absorbance was measured spectrophotometrically at 530 nm.  
C. neoformans utilizes the laccase enzyme that catalyses the 
synthesis of melanin in the presence of the precursor molecule like 
L-DOPA. The laccase activity was determined in suspensions of 
permeabilized cells as performed by Ikeda et al., 2002 [11]. C. 
albicans was used as a negative control since it is reported to exhibit 
a lack of laccase enzyme production. The optical density of the 
supernatant obtained after each time interval was measured 
spectrophotometrically at 480 nm. 
Time kill assay was done to check the survival rate of C. neoformans 
with and without the test compound. The test compound at MICR80R 
concentration was added to the potato dextrose broth (PDB) and 
10P6Pcells/ml of C. neoformans was added. The suspension of PDB with 
test compound served as blank. Fluconazole served as positive 
control for which PDB and fluconazole suspension was taken as 
blank. The time course study was spectrophotometrically measured 
in terms of absorbance at 480 nm. 
The experimental results were expressed as mean±standard error of 
mean of triplicates. Where applicable, the data were subjected to 
one-way and two-way analysis of variance (ANOVA) followed by 
bonferroni post test. A p-value of ≤ 0.05 was regarded as significant. 
The present study showed that compound 1e exhibited retardation 
in growth with zone of inhibition of 12 mm and MICR80R of compound 
1e was calculated as 50µg/ml against C. neoformans.  
It was found that compound 1e exhibited 63.67% reduction of 
melanization in C. neoformans at MICR80R concentration (fig. 1). Earlier 
studies have reported that unpigmented conidia are unable to 
quench ROS and were effectively eradicated by the host defence 





Fig. 1: Reduction in melanin production. [A] Illustrates reduction in 
melanization in C. neoformans in the presence of compound 1e. The 
data are mean±SEM from 3 samples for each group and analyzed by 
one-way ANOVA where * P<0.05 significant from control; [B] (i) 
melanization produced in C. neoformans; (ii) reduction in melanin 
content of C. neoformans in presence of compound 1e 
 
Laccase enzyme is responsible for the oxidization of polyphenolic 
substrate and iron into reactive intermediates which causes cell 
membrane damage in the host [13]. The compound 1e exhibited a 
significant reduction in laccase activity of C. neoformans. The laccase 
activity was reduced to 57.44% after 4 h* of treatment with 
compound 1e as calculated from the slope obtained from the straight 
line equation. The activity exhibited by the C. albicans was used as a 
negative control since it has been reported to exhibit a lack of 






















Fig. 2: Illustrates the reduction of laccase activity in C. neoformans 
in the presence of compound 1e. The data are mean±SEM from 3 
samples for each group and analyzed by two-way ANOVA followed 
by Bonferroni Post-test where ** P<0.01 significant from control 
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Fig. 3: Illustrates absorbance of C. neoformans liquid culture at 600 
nm in the presence of fluconazole and compound 1e. The data are 
mean±SEM from 3 samples for each group and analyzed by two-
way ANOVA followed by Bonferroni Post-test where ** P<0.01 
significant from control 
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The Time-kill assay results have illustrated that the compound 1e 
inhibited the growth of C. neoformans cells in almost the same 
duration of time as reported for the commercially available drug, 
fluconazole (fig. 3). 
Amongst the synthesized biphenyl-2,6-diethanone derivatives, 
compound 1e exhibited maximum antifungal activity against C. 
neoformans which may be attributed to the presence of nitrogen in 
the biphenyl scaffold. Thus, biphenyl-2,6-diethanone derivatives can 
behave as potentially promising antifungal agent. Present study 
concludes that compound 1e had a potential role in inhibition of 
melanin synthesis and laccase activity hence, can be used as 
therapeutic agents to kill C. neoformans or in the treatment of 
infected persons. 
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